Responsive risk assessment tool for drug criticality and vulnerability for Health Canada
Solicitation number 1000269703
Publication date
Closing date and time 2026/03/09 14:00 EDT
Last amendment date
Description
Health Canada has a requirement for access to information products to support the determination of shortage risk for drugs and the maintenance CVDL. We require that these information products provide us data and risk assessments showing the likelihood that a shortage of a drug would cause harm (criticality) and the likelihood of a drug going into shortage (vulnerability). The data must be on a web platform that can be accessed by Health Canada employees.
Contract duration
The estimated contract period will be 12 month(s), with a proposed start date of 2026/03/23.
Trade agreements
-
Canada-Chile Free Trade Agreement (CCFTA)
-
Canada-Peru Free Trade Agreement (CPFTA)
-
Canada-Colombia Free Trade Agreement
-
Canada-Panama Free Trade Agreement
-
Canada-Honduras Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canadian Free Trade Agreement (CFTA)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
Exclusive Rights
Contact information
Contracting organization
- Organization
-
Department of Health (HC)
- Address
-
200 Eglantine Driveway, Turney's Pasture
Ottawa, ON, K1A 0K9Canada
- Contracting authority
- Matthew Gazo
- Email
- Matthew.Gazo@hc-sc.gc.ca
Bidding details
| Document title | Amendment no. | Language | Unique downloads | Date added |
|---|---|---|---|---|
| 1000269703 ACAN.pdf | 001 | EN | 13 | 2026/02/24 |
| 1000269703 ACAN FR.pdf | 001 | FR | 2 | 2026/02/24 |